home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

245 rows where filing_period = "fourth_quarter", filing_year = 2016 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 245 ✖

filing_year 1

  • 2016 · 245 ✖

filing_period 1

  • fourth_quarter · 245 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1907130 FROST BROWN TODD LLC dc15852f-9db1-4831-ba3a-9a38444e844c 4T FROST BROWN TODD LLC 283572 APPRISS 2016 fourth_quarter PHA Issues relating to prescription drug monitoring programs (PDMPs): criminal justice/health care policy/appropriations. HOUSE OF REPRESENTATIVES 20000   0 1 2016-11-29T14:02:48.887000-05:00
1908444 VAN SCOYOC ASSOCIATES fe6b4522-ee85-4afe-9622-48943f40bf74 4T VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2016 fourth_quarter PHA No lobbying activity. Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 1 2016-12-30T20:03:34.880000-05:00
1908457 VAN SCOYOC ASSOCIATES c279995d-6e1d-4f60-ace4-92ef29134dc6 Q4 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2016 fourth_quarter PHA Public Law 114-92, National Defense Authorization Act for Fiscal Year 2016, Defensewide RDT&E and Defense Health Program; and Medication Therapy Management. Monitor the following: H.R.4190, To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services, Provider status. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2016-12-30T20:07:36.270000-05:00
1908460 VAN SCOYOC ASSOCIATES 4c083b26-49a3-4b94-834c-9478fdf2ab4d 4T VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2016 fourth_quarter PHA No lobbying activity. HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE 50000   0 1 2016-12-30T20:10:37.693000-05:00
1909103 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 37abaca1-2cdb-41b4-8bdb-137f16c33d0c Q4 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 401103437 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 2016 fourth_quarter PHA November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee Advisory Committee Meeting (topical compounds) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE     0 0 2017-01-05T11:21:42-05:00
1909141 MR. BRIAN KELLY d7ec68e9-a9a8-4d48-b723-ccd2b886eb37 Q4 MR. BRIAN KELLY 40024191 LUNDBECK PHARMACEUTICALS 2016 fourth_quarter PHA FDA Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-01-05T11:56:58-05:00
1909160 NELSON MULLINS RILEY & SCARBOROUGH f9fbbf42-3f15-4e80-9256-e210eae5db28 Q4 NELSON MULLINS RILEY & SCARBOROUGH 285871 CASCADE HEMOPHILIA CONSORTIUM 2016 fourth_quarter PHA Issues related to 340B Drug Pricing Progam HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-01-05T12:08:54-05:00
1909163 NELSON MULLINS RILEY & SCARBOROUGH 766b008b-3be5-4d2c-afa5-635860dbf732 Q4 NELSON MULLINS RILEY & SCARBOROUGH 285871 HEMOPHILIA OF GEORGIA 2016 fourth_quarter PHA Issues related to implementation of the ACA, Hemophilia research and treatments, and the 340B Drug Pricing Program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-01-05T12:10:30-05:00
1909366 CARD & ASSOCIATES, LLC 4b45ea96-8d85-4c16-b39b-e6af76b1809e Q4 CARD & ASSOCIATES, LLC 84217 AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY) 2016 fourth_quarter PHA Educate Members on pharmacy contracting with pharmacy benefit managers HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2017-01-05T17:11:49-05:00
1909369 CARD & ASSOCIATES, LLC ec4ffcfb-acfd-4b6b-8748-c4f8afc9a328 4T CARD & ASSOCIATES, LLC 84217 ALLIANCE HEALTH NETWORKS, LLC 2016 fourth_quarter PHA Educate Members on pharmacy contracting with pharmacy benefit managers HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2017-01-05T17:17:19-05:00
1909371 CARD & ASSOCIATES, LLC 57843b37-4b66-4f73-a246-1ca00c6ba7e6 4T CARD & ASSOCIATES, LLC 84217 AMERICANS FOR PRESCRIPTION DRUG FAIRNESS 2016 fourth_quarter PHA Advocate for protection of 340B drug pricing program and support 340B program integrity and compliance by covered entities and pharmacies HOUSE OF REPRESENTATIVES,SENATE 45000   0 1 2017-01-05T17:19:23-05:00
1909982 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 9ec8f2a7-d9da-4c9d-b634-9a36ee4427f1 Q4 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 11003 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 2016 fourth_quarter PHA ICYMI: CAGW Releases Report on Pharmaceutical Price Controls ICYMI: CAGW Releases Report on Pharmaceutical Price Controls HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-01-09T11:33:39-05:00
1910026 KATE MOSS 584cc3b4-36bc-49f6-95b3-6250f8f5fd12 Q4 KATE MOSS 25988 CVS HEALTH 2016 fourth_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-01-09T12:22:18-05:00
1910142 PRINTING INDUSTRIES OF AMERICA, INC. a7f507be-9e3e-4613-ab43-aa87b7d4c210 Q4 PRINTING INDUSTRIES OF AMERICA, INC. 32203 PRINTING INDUSTRIES OF AMERICA INC 2016 fourth_quarter PHA Pharmaceutical Printed Literature Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,U.S. Postal Service (USPS)   80000 0 0 2017-01-09T15:12:25-05:00
1910390 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d92ea63f-bf7f-4ccb-a47e-3e5cb2191b3e Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2016 fourth_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2017-01-10T09:24:49-05:00
1910398 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 212715e4-c69c-475b-8c30-66fba29ad757 Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2016 fourth_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-01-10T09:26:24-05:00
1910412 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e927efd9-fc52-4f06-b2fb-805a7f22395b Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2016 fourth_quarter PHA issues related to the 340B drug discount program Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-10T09:28:25-05:00
1910416 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 25c95c83-31df-4ce6-aa4d-47f485029dbe Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2016 fourth_quarter PHA HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-01-10T09:29:27-05:00
1910500 AMERICAN COLLEGE OF CLINICAL PHARMACY d3ddf61b-b24f-463a-b6b9-aa2098db339b Q4 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2016 fourth_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   128875 0 0 2017-01-10T10:50:29-05:00
1910889 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 90b6fb65-0a58-4ca3-8b3e-38282c1831eb Q4 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2016 fourth_quarter PHA Any language supporting the expanded use of virtual care/telemedicine, including HR 2799 supporting changes in definitions to expand the use of telemedicine. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   26803 0 0 2017-01-10T16:14:45-05:00
1910926 WAXMAN STRATEGIES b62dacb4-3688-45d4-bacf-798a3ae6ec08 Q4 WAXMAN STRATEGIES 401103693 340B HEALTH 2016 fourth_quarter PHA Laws and regulations affecting the 340B Drug Discount Program Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),White House Office 18750   0 0 2017-01-10T17:06:08-05:00
1911271 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 938d0f85-979e-4c68-8057-01f074438165 Q4 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2016 fourth_quarter PHA Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding. Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE,Veterans Affairs, Dept of (VA)   60000 0 0 2017-01-11T14:36:00-05:00
1911327 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 37e847b6-0844-445b-8078-fe1f2f6cded0 4A SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2016 fourth_quarter PHA Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding. Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE,Veterans Affairs, Dept of (VA)   60000 0 0 2017-01-11T15:33:15-05:00
1911929 MR. GALEN RESER 0e1e9ce9-0b65-436c-ac3b-8798943b08f2 Q4 MR. GALEN RESER 401055978 PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) 2016 fourth_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. "Fairness to Pet Owners Act of 2015," S.1200. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-01-12T15:32:08-05:00
1911999 RED+BLUE STRATEGIES 81800efa-03ff-4867-9deb-d20cad0b3ec0 Q4 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2016 fourth_quarter PHA P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid funding and other prescription drug related issues. National Defense Authorization Act of FY 2017 - Work to ensure that the current treatment of mail order for retired and active military personnel and their families remains constant in the pending Authorization bill. The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to mail order coverage for Medicare, Medicaid, Exchanges, Tricare and other programs. Issues related to the pricing of prescription medications. Rules, regulations, guidance and potential legislation specific to prescription drug pricing, generic utilization, biosimilars medications and specialty pharmacy. Issues related to the treatment of pharmacy benefit managers in federal programs. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Issues related to access and affordability for prescription medications for both government and private sector benefit programs. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-12T16:08:09-05:00
1912023 RED+BLUE STRATEGIES cbfcf8d3-66fe-499f-a7e9-c38651bae151 Q4 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2016 fourth_quarter PHA P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid issues and other prescription drug - related policies. The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. H.R. 2646- The Helping Families in Mental Health Crisis Act - Issues related to prescription drug coverage and benefits. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. H.R. 244 - The MAC Transparency Act. Clarifying current policies on pricing transparency for prescription drugs that exist under current law and regulatory policies. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to Senate Finance Committee activity on advances in chronic care with a focus on medication-based therapies. Work focused on Medicare Part D and related regulations and reports specific to pharmacy networks. Issues related to the implementation of the health care law that impact public and private sector pharmacy benefits. Issues related to pricing and access to prescription drugs including specialty drugs and biosimilars. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-12T16:26:34-05:00
1912032 RED+BLUE STRATEGIES 2735971c-6aae-49c3-981d-5d61c36bbbe8 Q4 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2016 fourth_quarter PHA P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid issues, policies focused on antibiotic resistance and other public health related policies. S. 524 - The Comprehensive Addiction and Recovery Act - supporting efforts to fight opioid abuse in the United States. Work focused on the inclusion of "lock in" programs in the Medicare program to prevent and protect seniors from opioid addiction. S.185 - The Promise for Antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. S. 2153 - Provider Payment Sunshine Act - policies supporting the inclusion of all prescribers to the Open Payments program. H.R. 5054 - Agriculture Appropriations Bill for FY 2017 - Issues related to FDA treatment of antibiotics and compounding of certain pharmaceuticals. Legislative and regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Advancing provisions to highlight Antibiotic Innovation and combating prescription drug abuse in the President's FY 2017 budget. Supporting policies to maintain the integrity of laws regarding compounding of certain medications. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2017-01-12T16:33:01-05:00
1912445 ACADEMY OF MANAGED CARE PHARMACY d80eef78-b052-4f2f-8077-6a7b069e5f45 Q4 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2016 fourth_quarter PHA Medicare Part D issues concerning managed care pharmacy, comments to FDA on BsUFA II reauthorization citing a need for biosimilars education and post market surveillance, comments in support of 21st Century Cures Act to support Section 3037 - Health care economic information, comments to CMS regarding implementation of CARA - P.L. 114-198, and comments to CMS on Medicare Part D MTM program. Meetings with Congressional office staff to seek support for amending current law consistent with HIPAA to allow health plans to access patient addiction records. Meeting with OMB to discuss impact of the SAMSHA pending final rule on confidentiality of substance abuse records (42 CFR Part 2). Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   158000 0 0 2017-01-13T11:16:14-05:00
1912543 OREGON HEALTH & SCIENCE UNIVERSITY 754615d8-06ba-46ae-8912-3d84b426a769 Q4 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2016 fourth_quarter PHA 340b Drug Discount Program for safety net hospitals and Health Resources and Services Administration proposed omnibus guidance. HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2017-01-13T11:54:18-05:00
1912588 ROCK & ASSOCIATES 44d59367-4b9b-4f6d-929b-ee32ef81613e Q4 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:21:44-05:00
1912596 ROCK & ASSOCIATES 6eaaa547-b023-40ae-b890-993243d13388 Q4 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:24:37-05:00
1912601 ROCK & ASSOCIATES 4ea9fd31-46e0-49e0-a2ce-672b18aaaba7 Q4 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:25:28-05:00
1912604 ROCK & ASSOCIATES 74aed679-1ccb-4a1a-b996-498f1c829368 Q4 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:26:23-05:00
1912611 ROCK & ASSOCIATES 1cfb61dc-a8c4-47c5-8a88-336e262bd254 Q4 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:27:24-05:00
1912618 ROCK & ASSOCIATES 5313ef39-8662-4915-8fb6-cbc92fce57c5 Q4 ROCK & ASSOCIATES 33545 WELLNESS PHARMACY 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-01-13T12:28:07-05:00
1912735 HOLLAND & KNIGHT LLP 41af72f9-658f-4458-9c86-5e7daea700a0 Q4 HOLLAND & KNIGHT LLP 18466 PROTECTING ACCESS TO PAIN RELIEF COALITION 2016 fourth_quarter PHA Advocating for policy to ensure patient access to pain relief. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-13T14:08:58-05:00
1912874 HOLLAND & KNIGHT LLP 698a1945-670d-4d1e-a707-64bc55b97cd5 Q4 HOLLAND & KNIGHT LLP 18466 THE BIOSIMILARS FORUM 2016 fourth_quarter PHA Medicare reimbursement issues, FDA regulation of biosimilars. HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2017-01-13T15:03:57-05:00
1912910 AMERICAN AMBULANCE ASSOCIATION 60a161b0-e7ab-4d2c-8be3-42483cfec00c Q4 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2016 fourth_quarter PHA Lobbied in support of the Protecting Patient Access to Emergency Medications Act (H.R. 4365, S. 2932) to ensure the continuity of standing orders for the administration of certain controlled substances by paramedics and EMTs to patients. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   260000 0 0 2017-01-13T15:23:16-05:00
1913175 RED+BLUE STRATEGIES 45e34e8e-e10d-4273-bf77-136b0ad0e47d Q4 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2016 fourth_quarter PHA PL - 114- 255 - 21st Century Cures Act. Provisions to include help fight against opioid abuse. H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs. S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-13T17:14:48-05:00
1913210 RED+BLUE STRATEGIES 1c98b72e-db1d-4658-8df0-b1209f1110e1 Q4 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2016 fourth_quarter PHA H.R. 5054 - Agriculture Appropriations Bill for FY 2017- issues related to finding the Food and Drug Administration's Office of Biosimilars. Education and advocacy related to what elements are necessary to ensure a hospitable environment to grow the new Biosimilars market in the United States and the positive impact these medications will have on drug cost and access. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-13T17:27:50-05:00
1913308 THE INGRAM GROUP LLC fad97564-4a35-4e4d-8b33-a534ed83b9c1 Q4 THE INGRAM GROUP LLC 400577737 ELI LILLY AND COMPANY 2016 fourth_quarter PHA S.2030, Advancing Targeted Therapies for Rare Diseases Act of 2015. H.R.34, 21st Century Cures Act (P.L.114-255). H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254). General issues related to the biopharmaceutical and pharmaceutical industries. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-01-14T11:44:54-05:00
1913638 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2d09b033-9a99-44f2-9fd0-8c11cbfd801c Q4 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2016 fourth_quarter PHA Opioid Abuse; Opioid Education; Prescription Drugs HR 953 Introduced February 12, 2015 by James Sensenbrenner, Jr. (R-WI) Comprehensive Addiction and Recovery Act of 2015 Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states. New legislation aims to tackle this epidemic. The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953, was introduced by Sen. Sheldon Whitehouse (D-RI) and Rep. Jim Sensenbrenner (R-WI5) and will receive a hearing on Thursday from the Senate Judiciary Committee. HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement -Act of 2015 Introduced June 17, 2915 by Susan Brooks (R-IN) This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication. HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   2160000 0 0 2017-01-15T21:24:38-05:00
1913923 THORSEN FRENCH ADVOCACY LLC b54814c2-02ec-4ab7-a40d-20072bc3d846 Q4 THORSEN FRENCH ADVOCACY LLC 400599826 CARDINAL HEALTH, INC. 2016 fourth_quarter PHA Issues related to prescription drug abuse. Issues related to pharmaceutical market value. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-16T13:03:02-05:00
1913927 INDEPENDENT PHARMACY COOPERATIVE ab0d8613-cfe8-4fa0-9b11-7bbd7a3c25ca Q4 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2016 fourth_quarter PHA H.R. 592/S.314 Pharmacy and Medically Underserved Areas Enhancement Act. IPC is supportive of pharmacists being recognized as providers under Medicare Part B for these areas. H.R. 793 Ensuring Seniors Access to Local Pharmacies Act. IPC is support of local pharmacies being able to participate in Medicare Part D in these underserved areas. S.524 Comprehensive Addiction and Recovery Act of 2016. IPC was against law as written. Actual Acquisition Cost (AAC) adoption with state Medicaid programs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-01-16T13:04:24-05:00
1913950 THORSEN FRENCH ADVOCACY LLC d4e597c4-85ed-4463-9a13-03517af386b4 Q4 THORSEN FRENCH ADVOCACY LLC 400599826 HEALTHCARE DISTRIBUTION ALLIANCE 2016 fourth_quarter PHA General issues related to prescription drug abuse. Issues related to pharmaceutical market value. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-16T13:22:18-05:00
1913965 THORSEN FRENCH ADVOCACY LLC 429aa3e6-3406-4d8c-9fba-1f9d01b03064 Q4 THORSEN FRENCH ADVOCACY LLC 400599826 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2016 fourth_quarter PHA Issues related to pharmaceutical market value. Issues related to prescription drug abuse. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-16T13:29:02-05:00
1913972 THORN RUN PARTNERS ee2cfbb6-3d0c-4b9d-a609-71a5e514511e Q4 THORN RUN PARTNERS 400534596 EXPRESS SCRIPTS, INC. 2016 fourth_quarter PHA H.R.244, MAC Transparency Act; pharmacy benefits manager standards under the Medicare prescription drug program to further transparency of payment methodologies to pharmacies. P.L.114-328, National Defense Authorization Act for Fiscal Year 2017; provision authorizing a pilot program in TRICARE that would establish Department of Defense (DoD) acquisition cost parity for prescription drugs obtained at community pharmacies. Drug reimbursement and general pharmacy related issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-16T13:32:07-05:00
1915353 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS d7cfdfa6-cdbe-444f-b37c-97ba9dd4159f Q4 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2016 fourth_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Contact concerning the Drug Quality and Security Act, all titles. Communication with the FDA on Generic Drug User Fee Act, Prescription Drug User Fee Act, Biosimilar User Fee Act, and electronic drug information. Expressed support for S. 524, Comprehensive Addiction and Recovery Act of 2016. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   230000 0 0 2017-01-17T13:23:23-05:00
1915457 KOUNTOUPES DENHAM CARR & REID, LLC cf7669d4-f9fe-4191-8be3-af429df08f75 Q4 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2016 fourth_quarter PHA General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues related to the over the counter drug monograph process. Issues related to the disposal of unused over the counter drugs. Issues related to the FDA regulatory process by which prescription medicines are switched to Over the Counter. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-17T13:46:24-05:00
1915474 MEHLMAN CONSULTING, INC. a68fa7df-990e-49b9-83a3-1f2f7c82a7db Q4 MEHLMAN CONSULTING, INC. 284950 THE CAMPAIGN FOR SUSTAINABLE RX PRICING 2016 fourth_quarter PHA Issues related to transparency and competition in the prescription drug market. S.3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES). S. 3335, Fair Accountability and Innovative Research Drug Pricing Act of 2016 (FAIR). Food and Drug Administration Appropriations Act. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-01-17T13:54:23-05:00
1915551 PARRY, ROMANI, DECONCINI & SYMMS 30b8e8b1-790c-4161-b6e9-e6fb5a18aa33 Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 ROCK & ASSOCIATES 2016 fourth_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2017-01-17T14:17:52-05:00
1915914 PRIME THERAPEUTICS 12432f87-3c38-4bd8-bac4-0e97f0cbe9d1 Q4 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2016 fourth_quarter PHA H.R.4784: Lower Drug Costs Through Competition Act, support increasing generic availability. S.2680: A bill to amend the Public Health Service Act to provide comprehensive mental health reform, and for other purposes. S.2615: the Increasing Competition in Pharmaceuticals Act. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2017-01-17T16:00:42-05:00
1915930 RUBICON ADVISORS, LLC 77918752-a906-4ca9-bba2-ea45af04a2d4 Q4 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2016 fourth_quarter PHA 21st Century Cures Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2017-01-17T16:06:33-05:00
1915935 RUBICON ADVISORS, LLC 9f08491b-61a1-410a-8597-1a8f76db91a1 Q4 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2016 fourth_quarter PHA Pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-01-17T16:07:45-05:00
1915940 RUBICON ADVISORS, LLC c04249b4-8b94-48b9-9f64-02569a0a1b76 Q4 RUBICON ADVISORS, LLC 315091 ALLIANCE TO PREVENT THE ABUSE OF MEDICINES 2016 fourth_quarter PHA Prescription drug abuse policy HOUSE OF REPRESENTATIVES,SENATE 82500   0 0 2017-01-17T16:09:35-05:00
1915941 RUBICON ADVISORS, LLC 45ed3506-95d7-45f2-a5f5-f11ec78e9d7e Q4 RUBICON ADVISORS, LLC 315091 COLLEGE OF AMERICAN PATHOLOGISTS 2016 fourth_quarter PHA Physician Payment Rates, Electronic Health Records Incentives program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-01-17T16:11:00-05:00
1915942 RUBICON ADVISORS, LLC 88709b29-7334-4f8b-b646-c15d84f8d47b Q4 RUBICON ADVISORS, LLC 315091 DR. REDDY'S LABORATORIES, LTD 2016 fourth_quarter PHA Food and Drug Administration, Generic Drug User Fees, NHI, DEA Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 45000   0 0 2017-01-17T16:12:32-05:00
1916379 FTI GOVERNMENT AFFAIRS 5518691a-7e41-41ac-940f-fff6a0f0682c Q4 FTI GOVERNMENT AFFAIRS 401054971 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2016 fourth_quarter PHA Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-17T19:25:18-05:00
1916572 CROSSROADS STRATEGIES, LLC 31297d39-56ee-4f1f-951c-3ab1469e4ab3 Q4 CROSSROADS STRATEGIES, LLC 400531586 EMD SERONO, INC. 2016 fourth_quarter PHA General pharmaceutical coverage and reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-17T23:13:32-05:00
1916585 SAFEWAY INC. 05fb4d81-4249-48c2-af16-a1324a88862c Q4 SAFEWAY INC. 300173 SAFEWAY 2016 fourth_quarter PHA H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions. H.R. 4909, FY 2017 National Defense Authorization Act, provisions related to TRICARE and pharmacy access. H.R. 953/S. 524, Comprehensive Addition and Recovery Act, provisions related to state prescription drug monitoring programs. H.R. 793/S. 1190, Ensuring Seniors Access to Local Pharmacies Act of 2015, all provisions. H.R. 3250, DXM Abuse Prevention Act, provisions related to retail pharmacy. HOUSE OF REPRESENTATIVES,SENATE   220000 0 0 2017-01-17T23:46:08-05:00
1916673 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION c28f2f31-f87f-4a40-abb8-e7abaceb9e42 Q4 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2016 fourth_quarter PHA H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees; Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE   245000 0 0 2017-01-18T08:03:41-05:00
1916914 GREATER NEW YORK HOSPITAL ASSOCIATION 32dcd141-36a5-4cc3-bfed-2f49bc644196 Q4 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2016 fourth_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases and support draft reform legislation; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment, oppose use of savings from home infusion payment reform for purposes other than creating a Medicare home infusion benefit; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments and Capitol Hill meetings on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6, now P.L.114-255) - … Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   400000 0 0 2017-01-18T10:00:04-05:00
1917348 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 64a55a73-bb33-4aff-b5c8-49a437f01520 Q4 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2016 fourth_quarter PHA H.R.5194 - 114th Congress (2015-2016)Safe Drug Disposal Tax Credit Act of 2016 H.R. 2841 the FAST Generics Act of 2015. S.3056: CREATES Act of 2016. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   380000 0 0 2017-01-18T11:24:37-05:00
1917365 BLUECROSS BLUESHIELD OF TENNESSEE acc6b66f-e9bd-4a12-b8b7-e646a6fe37b7 Q4 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2016 fourth_quarter PHA Precision Medicine Act (S2713); General Pharmacy Issues (HR6/2713); opioid abuse (S524, HR953, HR2805, HR4499); specialty drug pricing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-01-18T11:29:16-05:00
1917421 THE D MAJOR GROUP cf47dc22-9d35-4d1d-9b03-2a0d1a56f48d Q4 THE D MAJOR GROUP 401103162 CVS CAREMARK 2016 fourth_quarter PHA Issues related to pharmacy delivery including S. 2615, The Increasing Competition in Pharmaceuticals Act; H.R. 34, The 21st Century Cures Act; and H.R. 244, The MAC Transparency Act. HOUSE OF REPRESENTATIVES,SENATE 34500   0 0 2017-01-18T11:34:40-05:00
1917689 WALTER CONSULTING c4c15172-b7d0-40fa-ac0e-b38bcde924a3 4T WALTER CONSULTING 301697 AMERISOURCEBERGEN CORPORATION 2016 fourth_quarter PHA H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2017-01-18T12:46:00-05:00
1917759 KOUNTOUPES DENHAM CARR & REID, LLC 7a29ea93-a4ac-4c3a-a7e6-ea128b46ea55 Q4 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CVS HEALTH 2016 fourth_quarter PHA General education about the pharmacy benefit manager/pharmacy industry. Issues related to H.R. 6, The 21st Century Cures Act. Affordability and pricing of pharmaceuticals. S.3455 the CREATES Act and H.R. 2841 the FAST Generics Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-18T12:56:07-05:00
1917787 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 81050dbf-876a-452c-8051-83c1b6244ae7 Q4 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2016 fourth_quarter PHA Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Extended Producer Responsibility/Pharmaceutical Stewardship (Drug Take-Back) H.R. 4931 - Pharmaceutical Stewardship Act of 2016. Requires the Drug Enforcement Administration to establish and implement a national pharmaceutical stewardship program to collect and dispose of prescription medications; all sections. H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 (COARA). Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants to assist State and local governments in addressing the national epidemic of opioid abuse, and for other purposes (all sections). S. 524 - Comprehensive Addiction and Recovery Act of 2016 (CARA; became P.L. 114-198 on 7/22/2016). Authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use, and to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes (Section 201 - expands eligible uses of grant funds to include drug take-back efforts; Section 203 requires coordination among multiple government agencies to develop a prescription drug take-back program). Oral Contraceptives H.R. 5138 - Over-the-Counter Contraceptives Act of 2016. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. S. 1438 - Allowing Greater Access to Safe and Effective Contraception Act. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-… Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   370000 0 0 2017-01-18T13:00:16-05:00
1917850 CHAMBER HILL STRATEGIES 676a23d0-5f30-4f91-b1ad-1edd18fdee0e Q4 CHAMBER HILL STRATEGIES 400645947 AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) 2016 fourth_quarter PHA Implementation issues related to P.L. 113-54, the Drug Quality and Security Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-18T13:18:10-05:00
1917866 JOHNS HOPKINS UNIVERSITY 77e16c14-dd5a-4c17-911a-40eee1cb6de0 Q4 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2016 fourth_quarter PHA Pharmaceutical drug prices Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,White House Office   90000 0 0 2017-01-18T13:23:10-05:00
1918334 HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC dc0d01de-c2d1-4b91-9191-b352513c2571 4T HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC 17966 ELI LILLY AND COMPANY 2016 fourth_quarter PHA Policy issues relating to prescription drug prices.   30000   0 1 2017-01-18T14:38:09-05:00
1918584 POWERS PYLES SUTTER & VERVILLE, P.C. ee282b4f-7ff5-4da6-8565-57ba6a2fa3b7 Q4 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 340B HEALTH 2016 fourth_quarter PHA Section 340B of the Public Health Services Act, Section 1927 of the Social Security Act and issues related to (1) administration and Congressional oversight of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, and (3) funding of the Health Resources and Services Administration (HRSA)under the Labor Health & Human Services & Education appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-01-18T15:10:54-05:00
1918655 THE PROCTER AND GAMBLE COMPANY 8c948a71-7f26-4be2-9efd-83994728de4c Q4 THE PROCTER AND GAMBLE COMPANY 32225 THE PROCTER AND GAMBLE COMPANY 2016 fourth_quarter PHA - Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR)   779741 0 0 2017-01-18T15:23:44-05:00
1918683 KOUNTOUPES DENHAM CARR & REID, LLC 1339f8fc-be05-4e23-b069-05657407563a Q4 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2016 fourth_quarter PHA Policy matters related to generic pharmaceuticals and biosimilars including naming, labeling, access and interchangeability and changes to the Risk Evaluation and Mitigation Strategies (REMS) program, H.R.2841, FAST Generics Act of 2015 and S.3056, The CREATES Act, access to samples for generic testing, including S.3455, the Pharmaceutical Supply and Value Enhancement (SAVE) Act. The 21st Century Cures Act included in H. R. 2028, Further Continuing and Security Assistance Appropriations Act for Fiscal Year 2017. Affordability and pricing of pharmaceuticals. Issues related to drug takeback and opioid addiction. H. R. 4931, The Pharmaceutical Stewardship Act of 2016 and S.2977, The Budgeting for Opioid Addiction Treatment Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 60000   0 0 2017-01-18T15:28:16-05:00
1918702 AVANIR PHARMACEUTICALS aed0ca0a-14fd-45e5-b1cf-7347120198f5 Q4 AVANIR PHARMACEUTICALS 401103474 AVANIR PHARMACEUTICALS 2016 fourth_quarter PHA Drug pricing Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2017-01-18T15:31:54-05:00
1918892 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY b9cacca9-7b79-418a-addc-0a2320d9449f Q4 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY 401097063 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY 2016 fourth_quarter PHA 340B Program Mega Guidance HOUSE OF REPRESENTATIVES,SENATE   8124 0 0 2017-01-18T16:04:27-05:00
1919205 TARPLIN, DOWNS & YOUNG, LLC 098197d8-4607-40e3-a5ab-7a431b6fca7f Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2016 fourth_quarter PHA PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee sequester relief, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-01-18T16:46:29-05:00
1919446 TARPLIN, DOWNS & YOUNG, LLC 7300d101-a72c-4156-9525-f4f6a5d96b5b Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2016 fourth_quarter PHA PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2017-01-18T17:14:19-05:00
1919493 TARPLIN, DOWNS & YOUNG, LLC 0fda8461-744e-48bd-b169-f6ce694c2108 Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2016 fourth_quarter PHA Importation of prescription drugs (S. 122, H.R. 2228) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs (S. 480, H.R. 1725) Prescription Drug Abuse - General issues related to Rx drug abuse (H.R. 471, S. 483, S. 524, H.R. 953, H.R. 4641) 21st Century Cures (H.R. 6, H.R. 34) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-01-18T17:22:19-05:00
1919523 FOLEY HOAG LLP cb9a4ffc-d939-40f0-b9c9-f7c9bfd9403f Q4 FOLEY HOAG LLP 79610 GILEAD SCIENCES INC 2016 fourth_quarter PHA Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-18T17:28:51-05:00
1919531 TEVA PHARMACEUTICALS USA, INC. 7eb7825a-b4b9-43d0-909f-1b1cdfcc1e42 Q4 TEVA PHARMACEUTICALS USA, INC. 76695 TEVA PHARMACEUTICALS USA INC 2016 fourth_quarter PHA Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)   930000 0 0 2017-01-18T17:29:55-05:00
1919537 COVINGTON & BURLING LLP 9240641a-78d9-4c4f-b029-3681cf3508b1 Q4 COVINGTON & BURLING LLP 11195 CELGENE CORPORATION 2016 fourth_quarter PHA Opposing the CREATES Act, S. 3056 HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2017-01-18T17:32:36-05:00
1919562 TARPLIN, DOWNS & YOUNG, LLC 23a51528-f10d-4548-9402-1ada52295bba Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2016 fourth_quarter PHA PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies, user fee sequester, innovation Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-01-18T17:36:32-05:00
1919632 FTI GOVERNMENT AFFAIRS 1e473534-1cac-494d-8398-ba7c52b11c88 Q4 FTI GOVERNMENT AFFAIRS 401054971 PERRIGO, INC. 2016 fourth_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. "Fairness to Pet Owners Act of 2015," S.1200. HOUSE OF REPRESENTATIVES,SENATE 140000   0 0 2017-01-18T17:48:25-05:00
1919751 TROUTMAN STATEGIES 60c28d1f-d8e2-4351-842b-e7b7c650087f Q4 TROUTMAN STATEGIES 81511 DERMATRAN HEALTH SOLUTIONS LLC 2016 fourth_quarter PHA Monitor and lobby legislation and regulation relating to compounding pharmacies. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 40000   0 0 2017-01-18T18:16:21-05:00
1920592 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 58044adc-7e2a-40ae-975f-8e62030a06ca Q4 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2016 fourth_quarter PHA Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs (S. 480, H.R. 1725); Prescription Drug Abuse - General issues related to Rx drug abuse, (H.R. 471, S. 483, S. 524, H.R. 953, H.R. 4641); 21st Century Cures (H.R. 6, H.R. 34); Importation of Prescription Drugs (S. 122, H.R. 2228; Issues related to pharmaceutical market value Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   268000 0 0 2017-01-19T09:30:32-05:00
1920842 MASSACHUSETTS MEDICAL SOCIETY ffb95c22-b8b8-4a63-a663-4aa3d0ae204f Q4 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2016 fourth_quarter PHA Prescription Drug Pricing - no specific bill Direct to Consumer Advertising - no specific bill Negotiating Prescription Drug Prices for Medicare and Medicaid - no specific bill Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   50000 0 0 2017-01-19T10:02:25-05:00
1920866 NATIONAL HOME INFUSION ASSOCIATION 162ad177-ea33-4f4c-bc02-38b186026b98 Q4 NATIONAL HOME INFUSION ASSOCIATION 40047365 NATIONAL HOME INFUSION ASSOCIATION 2016 fourth_quarter PHA Compounding pharmacy regulation - worked to ensure the Drug Quality and Security Act (Pub.L. 113-54) is being properly implemented, specifically the draft memorandum of understanding for 503A pharmacies and FDA inspections of 503A pharmacies. Lobbied for the inclusion of Department of Agriculture/FDA appropriations language regarding inspection authority and scope of the draft memorandum of understanding. Lobbied on proper inspections of 503A pharmacies. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   125000 0 0 2017-01-19T10:04:31-05:00
1920984 FORBES-TATE d7679e46-e9ae-4755-bd6f-bb34aeb1b346 Q4 FORBES-TATE 400976792 PHRMA 2016 fourth_quarter PHA Issues related to Medicare Part D; Issues related to the drug industry; Issues related to comparative effectiveness; Issues related to follow-on biologics; Issues related to the Independent Payment Advisory Board; Issues related to patent reform; Issues related to ASP+6 and Part B rule; Issues related to PCORI; Issues related to pharmaceutical drug safety track and trace program legislation; Issues related to low income subsidies; Issues related to the Vice President's National Cancer Moonshot Initiative. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-01-19T10:16:19-05:00
1921134 AKIN GUMP STRAUSS HAUER & FELD 0123e625-7674-4de9-bb7a-62a34b62e51f Q4 AKIN GUMP STRAUSS HAUER & FELD 682 PHARMEDIUM SERVICES, LLC 2016 fourth_quarter PHA Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-01-19T10:33:15-05:00
1921457 QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) b28f424b-69c1-40f3-879c-16a9fa17117a Q4 QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) 54197 NEKTAR THERAPEUTICS 2016 fourth_quarter PHA FDA oversight of certain pain-reliever products HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-19T11:04:25-05:00
1921483 EVERGREEN ASSOCIATES, LTD. dcfbbdd9-6878-43a6-bbc3-d18c823a97d6 Q4 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2016 fourth_quarter PHA - Docket ID: FDA-2007-N-0363: Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Product - H.R. 5054/S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017: Title VII - General Provisions; Sec. 734 - (Draft) Cody Miller Patient Medication Information Act - H.R. 2028: Further Continuing and Security Assistance Appropriations Act, 2017: Division A - Further Continuing Appropriations Act, 2017, Sec. 101 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-01-19T11:06:24-05:00
1921661 FOLEY & LARDNER LLP ac60a372-51fa-4eba-a3d0-7047c3f3f378 Q4 FOLEY & LARDNER LLP 15042 ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY 2016 fourth_quarter PHA FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market; Issues relating to the Comprehensive Addiction and Recovery Act of 2016. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-01-19T11:21:33-05:00
1921771 FOLEY & LARDNER LLP a3134804-984b-404c-aad1-0f99f78b5bc0 Q4 FOLEY & LARDNER LLP 15042 PAR PHARMACEUTICAL 2016 fourth_quarter PHA FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market; Issues relating to the Comprehensive Addiction and Recovery Act of 2016. HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-01-19T11:32:40-05:00
1921934 MCDERMOTT+ LLC da196219-e312-4006-a6de-80e929bb4aaa Q4 MCDERMOTT+ LLC 401103287 ALLIANCE FOR RURAL HOSPITAL ACCESS 2016 fourth_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-19T11:47:36-05:00
1922562 BOCKORNY GROUP, INC. 7984370d-58d7-41db-9fb9-dcd7d6b85772 Q4 BOCKORNY GROUP, INC. 289773 CVS HEALTH INC 2016 fourth_quarter PHA Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. Issues related to reimbursement for Home Infusion HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-01-19T12:51:11-05:00
1922858 MERCURY PUBLIC AFFAIRS, LLC 968d1b23-cb18-4f46-963d-a3ebd6d05d8f Q4 MERCURY PUBLIC AFFAIRS, LLC 70175 KALISPELL REGIONAL HEALTHCARE 2016 fourth_quarter PHA Veteran pharmacy issues and polices Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2017-01-19T13:21:23-05:00
1923295 PD FRAZER CONSULTING, INC. bdf300f3-63d9-40c4-9f58-3771480b2c60 Q4 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2016 fourth_quarter PHA Of interest are S.122 Safe and Affordable Drugs From Canada Act of 2015 and H.R.2228 Safe and Affordable Drugs From Canada Act of 2015. Monitor the development of these proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-01-19T14:11:42-05:00
1923440 340B HEALTH 79d52073-6145-45e0-807d-bd4b40733df3 Q4 340B HEALTH 316434 340B HEALTH 2016 fourth_quarter PHA The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance,FY17 Labor Health and Human Services Appropriations,Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   179250 0 0 2017-01-19T14:23:36-05:00
1923510 THE CONAFAY GROUP, LLC 565df624-40b4-4742-9df3-23ca3dfe18bd Q4 THE CONAFAY GROUP, LLC 401004840 TROIA THERAPEUTICS INC. 2016 fourth_quarter PHA FDA Regulatory Process. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-01-19T14:37:01-05:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2882.703ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API